Entegris (ENTG) Is Up - What Are Investors Seeing in This Stock?

This afternoon we watched Entegris rise 3.0% to a price of $140.68 per share. The Large-Cap Plastics company is now trading -6.03% below its average target price of $149.7. Analysts have set target prices ranging from $125.0 to $164.0 per share for Entegris, and have given the stock an average rating of buy.

Entegris's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 3.0%. The stock's short ratio is 3.69. The company's insiders own 0.33% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 104.0%. In conclusion, we believe there is mixed market sentiment regarding Entegris.

Institutions Invested in Entegris

Date Reported Holder Percentage Shares Value
2024-03-31 Vanguard Group Inc 10% 14,666,653 $2,063,304,636
2024-03-31 Blackrock Inc. 10% 14,624,754 $2,057,410,285
2024-03-31 Price (T.Rowe) Associates Inc 9% 13,085,147 $1,840,818,384
2024-03-31 Sands Capital Management, LLC 5% 8,058,899 $1,133,725,852
2024-03-31 JP Morgan Chase & Company 4% 5,478,283 $770,684,812
2024-03-31 WCM Investment Management, LLC 3% 5,122,052 $720,570,237
2024-03-31 Select Equity Group, Inc. 3% 4,591,433 $645,922,760
2024-03-31 State Street Corporation 2% 3,052,567 $429,435,103
2024-03-31 Primecap Management Company 2% 2,982,829 $419,624,361
2024-03-31 London Company of Virginia, (The) 2% 2,922,174 $411,091,416
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.